Journal of International Psychiatry

[Abstract] Objective To study the clinical effects of Morita psychotherapy combined with buspirone in the treatment of obsessive-compulsive disorder (OCD). Methods Eighty-two patients with OCD who were treated in our hospital from January 2016 to April 2018 were enrolled, according to the order of admission, with 41 cases each. The control group was treated with buspirone. On the basis of this observation, the observation group was treated with Morita psychotherapy intervention. The clinical efficacy of the two groups was calculated after 12 weeks of intervention, and the Yale-Brown Forced Force Scale (Y-BOCS) before and after intervention was compared. The Hamilton Hamilton Anxiety Scale (HAMA) and Symptom Checklist (SCL-90) scores changed. Results The total effective rate of the observation group was 83.72%, which was higher than that of the control group (P<0.05). There was no significant difference between the two groups before and after the intervention of Y-BOCS and HAMA scores (P>0.05). At the 4th, 6th, 8th, and 12th week of intervention, the reduction of Y-BOCS and HAMA scores in the observation group was greater than that in the control group, and the Y-BOCS and HAMA scores in the observation group were smaller than those in the control group (P<0.05); The scores of the factors in the SCL-90 scale of the post-observation group were lower than those of the control group (P<0.05). Conclusion Morita psychotherapy combined with buspirone in the treatment of OCD patients can improve the degree of anxiety and coercion and psychological state of patients, and improve the clinical treatment effect.

[Key words] Buspirone;Obsessive-compulsive disorder; Morita psychotherapy; Obsession concept; Compulsive behavior